Politiparty
Politiparty

118th Congress Health

S. 935: Fair Accountability and Innovative Research Drug Pricing Act of 2023

Introduced

  1. Introduced (completed)Mar 22, 2023
  2. Passed Senate (not reached)
  3. Passed House (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in Senate, Mar 22, 2023

This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month.

Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug. Manufacturers are subject to civil penalties for failing to comply with the bill's requirements. Additionally, the Food and Drug Administration must post the information on its website.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

3

Bipartisan support.

Who scored on this bill

6 points earned
  1. 1Tammy Baldwin D-WI SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Tammy Baldwin

History

  1. Mar 22, 2023Introduced in the Senate by Tammy Baldwin.
Show the full action history (2 actions)
  1. Mar 22, 2023Introduced in Senate
  2. Mar 22, 2023Read twice and referred to the Committee on Health, Education, Labor, and Pensions.